Clinical trials: Normal Oocyte Donors

Normal Oocyte Donors

GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study

• Completed
• Age: 18 to 35 years

The aim of this randomized single center study is to explore the most optimal dose of GnRHa used for triggering of final oocyte maturation in IVF.

Trial name

NCT02208986

Testing

Triptorelin

Where

Vietnam

Volunteers

165 people

Sponsor

Vietnam National University